VIDEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Videx, and when can generic versions of Videx launch?
Videx is a drug marketed by Bristol and Bristol Myers Squibb and is included in four NDAs.
The generic ingredient in VIDEX is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.
Summary for VIDEX
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 123 |
Patent Applications: | 4,330 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VIDEX |
What excipients (inactive ingredients) are in VIDEX? | VIDEX excipients list |
DailyMed Link: | VIDEX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VIDEX
Paragraph IV (Patent) Challenges for VIDEX
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
VIDEX | Capsules | didanosine | 75 mg | 020155 | 1 | 2011-06-06 |
US Patents and Regulatory Information for VIDEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol | VIDEX | didanosine | FOR SOLUTION;ORAL | 020156-001 | Oct 9, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | VIDEX | didanosine | TABLET, CHEWABLE;ORAL | 020154-003 | Oct 9, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-005 | Oct 9, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-002 | Oct 31, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | VIDEX | didanosine | TABLET, CHEWABLE;ORAL | 020154-004 | Oct 9, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | VIDEX EC | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 021183-004 | Oct 31, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-003 | Oct 9, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VIDEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | VIDEX | didanosine | TABLET, CHEWABLE;ORAL | 020154-004 | Oct 9, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Bristol Myers Squibb | VIDEX | didanosine | TABLET, CHEWABLE;ORAL | 020154-003 | Oct 9, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-004 | Oct 9, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-004 | Oct 9, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Bristol | VIDEX | didanosine | FOR SOLUTION;ORAL | 020156-001 | Oct 9, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Bristol Myers Squibb | VIDEX | didanosine | TABLET, CHEWABLE;ORAL | 020154-004 | Oct 9, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-006 | Oct 9, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VIDEX
See the table below for patents covering VIDEX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 5832990 | ⤷ Try a Trial | |
Canada | 1269044 | INHIBITION DE L'INFECTIVITE IN VITRO ET DE L'EFFET CYTOPATHIQUE DU VIRUS HTLV-III/LAV PAR LA 2'3'-DIDEOXYINOSINE, LA 2'3'-DIDEOXYGUANOSINE OU LA 2'3'-DIDEOXYADENOSINE (INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2'3'-DIDEOXYINOSINE, 2'3' - DIDEOXYGUANOSINE, OR 2'3' -DIDEOXYADENOSINE) | ⤷ Try a Trial |
European Patent Office | 0493378 | ⤷ Try a Trial | |
New Zealand | 217185 | ALLEVIATING CYTOPATHIC EFFECTS OF HTLV-III VIRUS ON CELLS; PHARMACEUTICAL COMPOSITION | ⤷ Try a Trial |
Ireland | 922365 | ⤷ Try a Trial | |
European Patent Office | 0524579 | Formulations orales dosées et améliorées de dideoxy purine nucléosides (Improved oral dosing formulations of dideoxy purine nucleosides) | ⤷ Try a Trial |
Canada | 2074215 | FORMULATIONS ORALES AMELIOREES DE NUCLEOSIDES A BASE DE DIDEOXYPURINE (IMPROVED ORAL DOSING FORMULATIONS OF DIDEOXY PURINE NUCLEOSIDES) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for VIDEX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0285237 | 94C0006 | France | ⤷ Try a Trial | PRODUCT NAME: DIDANOSINE; NAT. REG.: 203 IS 225 F 3 19930331; FIRST REG.: FR 557 386-4 19920505 |
0216510 | 94C0006 | Belgium | ⤷ Try a Trial | PRODUCT NAME: DIDANOSINE; NAT. REG.: 203 IS 225 F 3 19930331; FIRST REG.: FR 557 386-4 19920505 |
0216510 | SZ 54/1994 | Austria | ⤷ Try a Trial | PRODUCT NAME: 2',3'-DIDEOXYINOSIN |
0216510 | SPC/GB94/005 | United Kingdom | ⤷ Try a Trial | SPC/GB94/005:, EXPIRES: 20070504 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |